Pseudoprogression and hyperprogression during immune checkpoint inhibitor therapy for urothelial and kidney cancer

OBJECTIVES: A small subset of patients treated with immune checkpoint inhibitors manifest atypical patterns of response, the so-called pseudoprogression (PP) and hyperprogression (HP). Their prevalence in urothelial (UC) and renal cancer (RCC) remains, to date, mostly uninvestigated. Therefore, we a...

Full description

Saved in:
Bibliographic Details
Published in:World J Urol
Main Authors: Soria, Francesco, Beleni, Andrea I., D’Andrea, David, Resch, Irene, Gust, Kilian M., Gontero, Paolo, Shariat, Shahrokh F.
Format: Artigo
Language:Inglês
Published: Springer Berlin Heidelberg 2018
Subjects:
Topic Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6208670/
https://ncbi.nlm.nih.gov/pubmed/29549485
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00345-018-2264-0
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items